If you simply look at their early global presence, breast reconstruction, thermal burn reconstruction, cardio reconstruction, government subsidy of their machines into every hospital in the real near-term, adipose variable stem cell therapy approvals and effectiveness over all others, and no more dilution of shares; then a very strong fourth quarter, perhaps earnings into single digit positive territory, should make people realize this is the next Amgen. I expect their market penetration to be astoundingly fast, with a great deal of profit on the front end. The Government already knows what Cytori can do for thermal burns, so the hurdles are simply a formality.
And all for a good cause. How many of us do not have at least one friend who suffers from either chronic heart failure, post mastectomy disfigurement, a childhood or recent burn causing disfigurement, pain and loss of mobility? And how many other people choose to have elective surgery with their own cells rather than silicon breast implants?
The world is changing fast, and yes, Management had to dilute shares and over promise to keep their global infrastructure strategy alive, but now the rubber is about to hit the road. I could care less about the shorts, earnings are what ultimately matter, and my guess is that they are about to astound and amaze for some time. Buckle up.